Key result
The WellFie smartphone app predicted systolic BP, diastolic BP, and heart rate with 93.9%, 92.9%, and 97.3% accuracy respectively compared to certified medical devices in normotensive adults.
Why the study?
Remote health monitoring gained interest during the COVID-19 pandemic, prompting evaluation of whether vital parameters can be determined contactless via smartphone-based remote photoplethysmography compared with certified medical devices.
Does smartphone-based remote photoplethysmography (WellFie application) accurately measure vital signs compared to certified medical devices in normotensive adults?
Cross-Sectional (n=150)
No
Does smartphone-based remote photoplethysmography (WellFie application) accurately measure vital signs compared to certified medical devices in normotensive adults?
Smartphone-based remote photoplethysmography can accurately determine blood pressure, heart rate, and respiratory rate in normotensive adults, offering a convenient contactless monitoring solution.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for smartphone BP/HR monitoring; prospective validation needed before any clinical use.
Background Remote health monitoring technologies gained interest in the context of COVID-19 pandemic with potential for contactless monitoring of clinical patient status. Here, we examined whether vital parameters can be determined in a contactless manner using a novel smartphone-based technology called remote photoplethysmography (rPPG) and compared with comparable certified medical devices. Methods We enrolled a total of 150 normotensive adults in this comparative cross-sectional validation study. We used an advanced machine learning algorithm in the WellFie application to create computational models that predict reference systolic, diastolic blood pressure (BP), heart rate (HR), and respiratory rate (RR) from facial blood flow data. This study compared the predictive accuracy of smartphone-based, rPPG-enabled WellFie application with comparable certified medical devices. Results When compared with reference standards, on average our models predicted systolic blood pressure (BP) with an accuracy of 93.94%, diastolic BP with an accuracy of 92.95%, HR with an accuracy of 97.34%, RR with accuracy of 84.44%. For the WellFie application, the relative mean absolute percentage error (RMAPE) for HR was 2.66%, for RR was 15.66%, for systolic BP was 6.06%, and for diastolic BP was 7.05%. Conclusion Our results on normotensive adults demonstrates that rPPG technology-enabled Wellfie application can determine BP, HR, RR in normotensive participants with an accuracy that is comparable to clinical standards. WellFie smartphone application based on rPPG technology offers a convenient contactless video-based remote solution that could be used in any modern smartphone.
No takes yet. Share an insight, caveat, or question.
Rajan et al. (2023) conducted a cross-sectional in Healthy normotensive adults (n=150). WellFie application (remote photoplethysmography) vs. Certified medical devices (Masimo pulse oximeter and Omron BP monitor) was evaluated on Predictive accuracy and relative mean absolute percentage error (RMAPE) for vital signs (HR, RR, systolic BP, diastolic BP) (Accuracy: Systolic BP 93.94%, Diastolic BP 92.95%, HR 97.34%, RR 84.44%). The WellFie smartphone app predicted systolic BP, diastolic BP, and heart rate with 93.9%, 92.9%, and 97.3% accuracy respectively compared to certified medical devices in normotensive adults.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: